Dr. Reddy's Recalls Flucanazole Tablets for Dissolution Failures
Dr. Reddy's Laboratories is recalling Flucanazole tablets because they failed dissolution and stability specifications.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the recall as FDA Class II. Per the rubric, FDA Class II recalls are classified as Severe (Score 4), as they may cause temporary or medically reversible adverse health consequences.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Flucanazole Tablets, USP, 50 mg. The recall involves 30-count and 100-count bottles manufactured in India. The specific NDC codes affected are 55111-143-30 and 55111-143-01.
The recall was initiated because the product failed dissolution specifications and an 18-month stability time point. The agency has classified this as a Class II recall, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The affected products were distributed nationwide. Consumers and healthcare providers should stop using the recalled lots and contact their healthcare provider or pharmacist for guidance on alternative treatments.
The recalled product
- Product
- FLUCONAZOLE (FLUCONAZOLE)
- Brand
- FLUCONAZOLE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Antifungal
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- a) 30 count C500221
- exp 12/2016
- C502342
- exp 03/2017 b) 100 count C500221
- exp 03/2017
UPCs (1)
- 0355111145127
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · FLUCONAZOLE
- SevereBaxter Recalls Fluconazole Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- ModerateHarvard Drug Group Recalls Fluconazole Tablets for Failed Dissolution
FDA (Drugs) · 2017-05-10
- ModerateFluconazole Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2017-05-10
- ModerateDr. Reddy's Recalls Flucanazole Tablets for Dissolution Failures
FDA (Drugs) · 2017-02-08
- ModerateDr. Reddy's Recalls Flucanazole Tablets Due to Dissolution Failures
FDA (Drugs) · 2017-02-08
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModerateMinocycline extended-release tablets failed dissolution testing during stability analysis
FDA (Drugs) · 2026-06-17